- Report
- June 2025
- 194 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 193 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 179 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 192 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 303 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 601 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 190 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 370 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 182 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 492 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 474 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- January 2025
- 125 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- September 2024
- 142 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- June 2025
- 93 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 529 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 216 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 283 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 368 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 285 Pages
Global
From €5240EUR$5,850USD£4,467GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more